focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.55
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.10 (18.182%)
Open: 0.60
High: 0.00
Low: 0.00
Prev. Close: 0.60
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule 1 - Provexis plc

6 Jun 2005 17:05

AIM06 June 2005 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH AIM RULE 2 ALL APPLICANTS MUST COMPLETE THE FOLLOWING: COMPANY NAME:Provexis plc COMPANY ADDRESS:10 Williams House Manchester Science Park Lloyd Street North Greater Manchester COMPANY POSTCODE:M15 6SE COUNTRY OF INCORPORATION:England and Wales COMPANY BUSINESS:Nutraceutical company which develops scientifically proven, proprietary, functional foods, supplements andmedical foods DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price to whichit seeks admission and the number and type to be held as treasury shares):249,628,324 ordinary shares of 1p each comprising: 33,218,388 shares (Capital reorganisation of Existing Shares) 67,424,000 shares (Placing) 111,658,555 shares (Vendor consideration) 37,327,381 shares (Loans conversion) CAPITAL TO BE RAISED ON ADMISSION:£3.8 million FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:Dawson Buck (Non-executive Chairman) Neville Bain (Non-executive Deputy Chairman) Stephen Franklin (Chief Executive) Stephen Moon (Commercial Director) PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUEDSHARE CAPITAL BEFORE ADMISSION: Number of ordinary Percentage of issued shares share capitalRising Stars Growth Fund 58,959,444 23.62Progeny BioVentures Limited 31,969,179 12.81ANGLE Technology Limited 29,926,464 11.99North West Equity Fund 13,514,990 5.41Rowett Research Services Limited 13,167,873 5.28 NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (G) OFTHE AIM RULES:None ANTICIPATED ACCOUNTING REFERENCE DATE:31 March EXPECTED ADMISSION DATE:23 June 2005 NAME AND ADDRESS OF NOMINATED ADVISER:Arbuthnot Securities Limited Arbuthnot House 20 Ropemaker Street London EC2Y 9AR NAME AND ADDRESS OF BROKER:Arbuthnot Securities Limited Arbuthnot House 20 Ropemaker Street London EC2Y 9AR DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH ASTATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITSSECURITIES:Arbuthnot Securities Limited Arbuthnot House 20 Ropemaker Street London EC2Y 9AR The Admission document contains full details about the applicant and the admission of itssecurities. DATE OF NOTIFICATION:6 June 2005 NEW/ UPDATE (see note):New QUOTED APPLICANTS MUST ALSO COMPLETE THE FOLLOWING:N/ATHE NAME OF THE AIM DESIGNATED MARKET UPON WHICH THE APPLICANT'S SECURITIES HAVE BEEN TRADED: THE DATE FROM WHICH THE APPLICANT'S SECURITIES HAVE BEEN SO TRADED: CONFIRMATION THAT, FOLLOWING DUE AND CAREFUL ENQUIRY, THE APPLICANT HAS ADHERED TO ANY LEGAL AND REGULATORYREQUIREMENTS INVOLVED IN HAVING ITS SECURITIES TRADED UPON SUCH A MARKET: AN ADDRESS OR WEB-SITE ADDRESS WHERE ANY DOCUMENTS OR ANNOUNCEMENTS WHICH THE APPLICANT HAS MADE PUBLIC OVER THELAST TWO YEARS (IN CONSEQUENCE OF HAVING ITS SECURITIES SO TRADED) ARE AVAILABLE: DETAILS OF THE APPLICANT'S STRATEGY FOLLOWING ADMISSION INCLUDING, IN THE CASE OF AN INVESTING COMPANY, DETAILSOF ITS INVESTMENT STRATEGY: A DESCRIPTION OF ANY SIGNIFICANT CHANGE IN FINANCIAL OR TRADING POSITION OF THE APPLICANT, WHICH HAS OCCURREDSINCE THE END OF THE LAST FINANCIAL PERIOD FOR WHICH AUDITED STATEMENTS HAVE BEEN PUBLISHED: A STATEMENT THAT THE DIRECTORS OF THE APPLICANT HAVE NO REASON TO BELIEVE THAT THE WORKING CAPITAL AVAILIABLE TOIT OF ITS GROUP WILL BE INSUFFICIENT FOR AT LEAST TWELVE MONTHS FROM THE DATE OF ITS ADMISSION: DETAILS OF ANY LOCK-IN ARRANGEMENTS PURSUANT TO RULE 7 OF THE AIM RULES: A BRIEF DESCRIPTION OF THE ARRANGEMENTS FOR SETTLING THE APPLICANT'S SECURITIES: A WEBSITE ADDRESS DETAILING THE RIGHTS ATTACHING TO THE APPLICANT'S SECURITIES: INFORMATION EQUIVALENT TO THAT REQUIRED FOR AN ADMISSION DOCUMENT WHICH IS NOT CURRENTLY PUBLIC: A WEBSITE ADDRESS OF A PAGE CONTAINING THE APPLICANT'S LATEST ANNUAL REPORT AND ACCOUNTS WHICH MUST HAVE AFINANCIAL YEAR END NOT MORE THEN NINE MONTHS PRIOR TO ADMISSION. THE ACCOUNTS MUST BE PREPARED ACCORDING TO UKOR US GAAP OR INTERNATIONAL ACCOUNTING STANDARDS. THE NUMBER OF EACH CLASS OF SECURITIES HELD IN TRESURY. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Nov 20134:40 pmRNSSecond Price Monitoring Extn
20th Nov 20134:35 pmRNSPrice Monitoring Extension
19th Nov 20132:30 pmRNSAdditional Listing
18th Nov 20139:34 amRNSShare Price Movement
30th Sep 20133:27 pmRNSResult of AGM
30th Sep 20137:00 amRNSAGM Statement
23rd Sep 20134:40 pmRNSSecond Price Monitoring Extn
23rd Sep 20134:35 pmRNSPrice Monitoring Extension
16th Sep 20134:40 pmRNSSecond Price Monitoring Extn
16th Sep 20134:35 pmRNSPrice Monitoring Extension
11th Sep 20137:00 amRNSDraw Down of Funds and Issue of Equity
6th Sep 20137:00 amRNSNotice of AGM
8th Aug 20137:00 amRNSDemerger Effective
5th Aug 20134:40 pmRNSSecond Price Monitoring Extn
5th Aug 20134:35 pmRNSPrice Monitoring Extension
15th Jul 20134:06 pmRNSResult of General Meeting
10th Jul 20134:35 pmRNSPrice Monitoring Extension
28th Jun 201311:03 amRNSFinal Results
28th Jun 201311:00 amRNSProposed demerger
27th Jun 201312:56 pmRNSAnnouncement in respect of market speculation
13th May 20137:00 amRNSChange of auditor
7th May 20134:40 pmRNSSecond Price Monitoring Extn
7th May 20134:35 pmRNSPrice Monitoring Extension
1st May 20137:00 amRNSSiS wins Tesco Supplier of the Year award
30th Apr 20137:00 amRNSFruitflow powder has GRAS status affirmed in US
28th Mar 20137:01 amRNSPre-close update
12th Feb 20137:00 amRNSSir Chris Hoy signs up as SiS ambassador
7th Jan 20137:00 amRNSSiS launch new REGO + Fruitflow gel
2nd Jan 20138:37 amRNSScience in Sport announce new partnership
6th Dec 20127:00 amRNSInterim Results
3rd Dec 20127:00 amRNSNotice of Results
11th Oct 20122:56 pmRNSResult of AGM
11th Oct 20127:00 amRNSAGM Statement
28th Aug 20127:00 amRNSDraw Down of Funds and Issue of Equity
6th Aug 201211:22 amRNSAnnual Report and Accounts
31st Jul 20127:00 amRNSFinal Results
27th Jul 20127:00 amRNSNotice of Results
31st May 20127:00 amRNSTotal Voting Rights
17th May 20127:00 amRNSDraw Down of Funds and Issue of Equity
24th Apr 20127:00 amRNSScience in Sport brand relaunch
23rd Apr 20124:31 pmRNSAdditional Listing
2nd Apr 20127:00 amRNSDirectorate Change
30th Mar 201211:46 amRNSTotal Voting Rights Update
30th Mar 20127:00 amRNSPre-Close Update
16th Mar 20124:35 pmRNSPrice Monitoring Extension
12th Mar 20124:40 pmRNSSecond Price Monitoring Extn
12th Mar 20124:35 pmRNSPrice Monitoring Extension
12th Mar 20127:00 amRNSScience in Sport Update
14th Feb 20127:00 amRNSFruitflow update
9th Jan 20124:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.